Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?

To: bill hopkins who wrote (777)	3/29/1998 10:19:00 AM
From: Solid	Read Replies (3) \| Respond to of 1055

Generally great thread. Factually, A GREAT COMPANY. J&J backing. #1 position. Basically pharm. sector alt. which is hot. Tremendous growth potential and actual, both domestic AND foreign. Actual debt is like what , zero? Future earnings make the appearence of a high PE VERY easy to understand. Remember PE is not high if growth rate is also very high. Dips appear as buying opportunity to me. Yes it may take a big dip at times, but soon, more folks will catch on to this eagles backside and ride it for long term appreciation, big time. I am long already and will ride, rather then miss opportunity. Anybody have any thoughts on Sept. Calls @ 70 strike price? 10 contracts becomes 20 @ half price and only a few points above current level of price with many months of news and growth before due date. Thanks in advance!